Education is Key to Improving Hepatitis B Vaccination Rates
Drug Topics
AUGUST 30, 2023
Resources with pertinent information are essential in motivating individuals to comply with vaccine recommendations.
Wed.Aug 30, 2023
465 
Medicare named the first 10 drugs up for negotiation. Now what?
PharmaVoice
AUGUST 30, 2023
The list of blockbuster cardiovascular, diabetes and cancer drugs gives the industry a window into how regulators are approaching price negotiations.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Ultrasound Imaging Treatment for Nonmelanoma Skin Cancer Exhibits 99% Cure Rate
Drug Topics
AUGUST 30, 2023
Image-Guided Superficial Radiation Therapy (IGSRT) directs low-level x-rays to specific areas, killing cancer cells without bleeding, pain, surgical scarring, or the need for reconstructive surgery.
Opioid Settlement May Spur Cannabis as Potential New Pharmacy Revenue Stream
Pharmacy Times
AUGUST 30, 2023
The opioid settlement framework could have a significant impact on the future of cannabis distribution and its role in health care.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MorningRX: August 30, 2023
Drug Topics
AUGUST 30, 2023
Narcan is set to be available at several drugstore and grocery chains in the US early next week, and Walmart announced a new "Testing and Treatment" program at its pharmacies in 12 states.
FDA Approves 0.9% Sodium Chloride Injection in 10, 20 mL Single-Dose Vials
Pharmacy Times
AUGUST 30, 2023
Sodium chloride injection contains sodium chloride in water and is administered intravenously, which is intended for a single-dose injection to replenish fluids and electrolytes.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Medicaid rebukes states for mistakenly disenrolling children
STAT
AUGUST 30, 2023
Medicaid warned states Wednesday that they could be mistakenly removing children from government insurance programs in a post-pandemic review of millions of enrollees. States may be unnecessarily disenrolling children from Medicaid or the Children’s Health Insurance Program because they are reviewing families as a whole despite there being a higher threshold to remove children from the programs.
Humana launches in-home primary care through CenterWell
Fierce Healthcare
AUGUST 30, 2023
Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes. | Humana's senior-focused primary care business, CenterWell, is bringing its services into patients' homes.
STAT+: J&J cuts the price of its lifesaving TB pill by more than half for many low- and middle-income countries
STAT
AUGUST 30, 2023
Amid controversy over access to a lifesaving tuberculosis pill, a new contracting effort is expected to lower the price for the medicine by as much as 55% in dozens of low- and middle-income countries, according to a group that administers a global fund for distributing TB drugs. But advocacy groups continue to argue that Johnson & Johnson, which makes the pill, has stymied wider access.
CMS suspects auto-renewal process at fault for wrongful Medicaid disenrollments
Fierce Healthcare
AUGUST 30, 2023
In a letter sent to all states (PDF), the Centers for Medicare & Medicaid Services ( | As more Medicaid beneficiaries are wrongly kicked off the program, CMS is requiring states to reevaluate its eligibility systems and auto-renewal process.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Unicorn down: Following layoffs, Biofourmis CEO quietly departs
STAT
AUGUST 30, 2023
A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role. A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic.
Researchers Find Increased Risk of Atrial Fibrillation After Menopause
Pharmacy Times
AUGUST 30, 2023
Stressful life events and poor sleeping patterns are linked to the development of atrial fibrillation in older women.
Providers can now see patients' insurance coverage in GoodRx's cost comparison tool
Fierce Healthcare
AUGUST 30, 2023
GoodRx has launched a new feature to allow healthcare professionals to see the cost of a patient’s prescription with their insurance. | The feature, embedded in GoodRx's provider solution, surfaces a patient’s coverage and benefits at the point of care with the goal of increasing price transparency and access to drugs.
CMS Announces First 10 Drugs To Undergo Price Negotiations Under Inflation Reduction Act
Pharmacy Times
AUGUST 30, 2023
Any new prices established after negotiations will be effective on January 1, 2026.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
How behavioral health app BeMe is aiming to connect with teens
Fierce Healthcare
AUGUST 30, 2023
In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. | In order to address deteriorating adolescent mental health, interventional behavioral health app BeMe Health moved to meet teens where they’re at—online. Amd according to new research, this methodology is proving successful.
Amid shortage, FDA clears several generics of Takeda's popular ADHD drug Vyvanse
Fierce Pharma
AUGUST 30, 2023
After 16 years on the market, Takeda's blockbuster attention-deficit/hyperactivity disorder (ADHD) med Vyvanse has finally reached its patent cliff. | After 16 years on the market, Takeda's blockbuster ADHD med Vyvanse has finally reached its patent cliff. And the FDA's approval of several generics comes amid a U.S. shortage of the drug.
Upcoming Phase 3 Clinical Program Will Examine Efficacy of Oral PCSK9 Inhibitor MK-0616 in Patients With Hypercholesterolemia
Pharmacy Times
AUGUST 30, 2023
The phase 3 clinical program, CORALreef, consists of 3 trials and is likely the first of its kind for an oral PCSK9 inhibitor, according to the study authors.
STAT+: Workforce, capacity constraints slow ramp-up of new Alzheimer’s drug Leqembi
STAT
AUGUST 30, 2023
The first Alzheimer’s therapy to clearly slow cognitive decline, approved in the United States last month, lifted the hope of patients and their families. But creating access to the program is a painfully slow process, even in Massachusetts, where large hospital systems have been preparing for months to administer the much-anticipated medicine.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
COVID-19 Infection May Cause Hypertension in Adults With No Pre-Existing Conditions
Pharmacy Times
AUGUST 30, 2023
Despite study findings showing that 1 in 5 patients hospitalized for COVID-19 developed persistent high blood pressure, many had underlying risk factors.
Amazon hikes free shipping minimum to $35 for non Prime members
Drug Store News
AUGUST 30, 2023
Non-Prime members previously have been required to spend $25 to qualify for free shipping.
RBX2660 Demonstrates Safe, Effective Results Treating Recurrent Clostridioides difficile Infection
Pharmacy Times
AUGUST 30, 2023
Investigators will continue to research RBX2660 in patients who are immunocompromised or who have chronic conditions with Clostridioides difficile infection.
Watch DSN: The Compliance Team touches on clinical services’ effect on pharmacy space
Drug Store News
AUGUST 30, 2023
At NACDS’ Total Store Expo, DSN caught up with The Compliance Team’s founder and CEO to discuss how clinical services are changing the retail pharmacy space.
Novo Nordisk buys another obesity biotech
pharmaphorum
AUGUST 30, 2023
Novo Nordisk buys another obesity biotech Phil.
Walmart kicks off Testing and Treatment Program at pharmacies in 12 states
Drug Store News
AUGUST 30, 2023
Under the program, Walmart pharmacists will test and treat customers for strep throat, flu and COVID-19.
As large employers back away from self-insurance, small- and medium-sized ones embrace it: EBRI
Fierce Healthcare
AUGUST 30, 2023
As large employers take a step back from self-insurance, small- and medium-sized employers are taking a step forward in embracing that coverage option, according to an issue brief by the Employee B | The share of large employers offering self-insurance options to employees steadily declined since the passage of the Affordable Care Act, with it dropping to 72% in 2022, the lowest it’s been since 2010, according to the EBRI.
Stetson and Luke Grimes saddle up to reignite the brand for the modern age
Drug Store News
AUGUST 30, 2023
In our Q&A with Stephen Mormoris, CEO of Scent Beauty, he shares how teaming up with Yellowstone star Luke Grimes is helping the fragrance reach a younger audience.
FibroGen slumps on second failed DMD study
pharmaphorum
AUGUST 30, 2023
FibroGen slumps on second failed DMD study Phil.
FDA turns down Outlook's ophthalmic version of Roche's Avastin over manufacturing, data shortfalls
Fierce Pharma
AUGUST 30, 2023
Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. | Even without an FDA approval, Roche’s cancer drug Avastin is widely used by doctors to treat certain eye diseases. Outlook Therapeutics has been trying to get an official approval for a reformulated version, but instead got a rejection letter.
Outlook slumps as FDA rejects eye disease drug
pharmaphorum
AUGUST 30, 2023
Outlook slumps as FDA rejects eye disease drug Phil.
STAT+: Pharmalittle: Winners and losers from Medicare drug-negotiation list; Novo strikes deal to keep lead in weight-loss drugs
STAT
AUGUST 30, 2023
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Our choice today is … cinnamon sticky bun.
Emergent BioSolutions' Narcan Nasal Spray launches OTC, retailers announce availability
Drug Store News
AUGUST 30, 2023
Emergent has shipped its OTC Narcan Naloxone HCl Nasal Spray 4 mg to mass drug, pharmacy and grocery stores, as well as online retailers.
Keytruda gets front-line gastric cancer okay in EU
pharmaphorum
AUGUST 30, 2023
Keytruda gets front-line gastric cancer okay in EU Phil.
Kroger, Bayer team up to improve access to health, nutrition in rural America
Drug Store News
AUGUST 30, 2023
Bayer and Kroger will support AgriSafe Network, an organization working to address health disparities in agricultural communities.
Let's personalize your content